From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...

The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.

The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...

Since becoming Vertex's top scientist in 2015, Altshuler has helped the company become an industry powerhouse. He’ll depart ...

The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.

Hearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop a more affordable ...